Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rain Oncology Inc. (RAIN) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Rain Oncology Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1724979.
Total stock buying since 2021: $100,217,425.
Total stock sales since 2021: $2,124,968.
Total stock option exercises since 2021: $92,987.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 1,372,418 | $1,446,694 | 1,168,973 | $1,453,162 | 0 | $0 |
| 2022 | 5,878,683 | $37,901,810 | 0 | $0 | 23,358 | $92,987 |
| 2021 | 3,683,902 | $60,868,921 | 50,000 | $671,806 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-12 | 0 | $0 | 173,973 | $209,412 | 0 | $0 |
| 2023-10 | 284,145 | $279,028 | 0 | $0 | 0 | $0 |
| 2023-06 | 333,325 | $368,324 | 0 | $0 | 0 | $0 |
| 2023-05 | 754,948 | $799,342 | 995,000 | $1,243,750 | 0 | $0 |
| 2022-11 | 5,295,955 | $31,151,947 | 0 | $0 | 0 | $0 |
| 2022-07 | 0 | $0 | 0 | $0 | 3,890 | $15,365 |
| 2022-06 | 25,000 | $57,250 | 0 | $0 | 0 | $0 |
| 2022-04 | 0 | $0 | 0 | $0 | 3,000 | $11,850 |
| 2022-03 | 0 | $0 | 0 | $0 | 16,468 | $65,772 |
| 2022-01 | 557,728 | $6,692,613 | 0 | $0 | 0 | $0 |
| 2021-10 | 0 | $0 | 50,000 | $671,806 | 0 | $0 |
| 2021-09 | 407,088 | $6,676,487 | 0 | $0 | 0 | $0 |
| 2021-07 | 587,002 | $9,078,691 | 0 | $0 | 0 | $0 |
| 2021-05 | 389,812 | $6,251,243 | 0 | $0 | 0 | $0 |
| 2021-04 | 2,300,000 | $38,862,500 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-12-18 | Tang Capital Partners Lp | Sale | 40,132 | 1.21 | 48,559 |
| 2023-12-15 | Tang Capital Partners Lp | Sale | 109,435 | 1.20 | 131,322 |
| 2023-12-14 | Tang Capital Partners Lp | Sale | 24,406 | 1.21 | 29,531 |
| 2023-10-13 | Tang Capital Partners Lp (10% Owner) | Buy | 131,631 | .99 | 130,314 |
| 2023-10-12 | Tang Capital Partners Lp (10% Owner) | Buy | 77,702 | .98 | 76,147 |
| 2023-10-11 | Tang Capital Partners Lp (10% Owner) | Buy | 74,812 | .97 | 72,567 |
| 2023-06-01 | Tang Capital Partners Lp (10% Owner) | Buy | 333,325 | 1.10 | 368,324 |
| 2023-05-31 | Tang Capital Partners Lp (10% Owner) | Buy | 166,180 | 1.09 | 181,136 |
| 2023-05-30 | Tang Capital Partners Lp (10% Owner) | Buy | 588,768 | 1.05 | 618,206 |
| 2023-05-22 | Davis Aaron I. | Sale | 995,000 | 1.25 | 1,243,750 |
| 2022-11-22 | Berger Franklin M | Buy | 77,000 | 8.27 | 636,790 |
| 2022-11-21 | Berger Franklin M | Buy | 45,000 | 7.80 | 351,000 |
| 2022-11-08 | Berger Franklin M (Director) | Buy | 42,881 | 5.83 | 249,996 |
| 2022-11-08 | Lampert Mark N | Buy | 3,420,716 | 5.83 | 19,942,774 |
| 2022-07-06 | Doebele Robert (See Remarks) | Option Ex | 3,890 | 3.95 | 15,365 |
| 2022-06-01 | Vellanki Avanish (Chairman and CEO) | Buy | 25,000 | 2.29 | 57,250 |
| 2022-04-13 | Doebele Robert (See Remarks) | Option Ex | 3,000 | 3.95 | 11,850 |
| 2022-03-31 | Doebele Robert (See Remarks) | Option Ex | 2,000 | 3.95 | 7,900 |
| 2022-03-11 | Vellanki Avanish (President and CEO) | Option Ex | 14,468 | 4.00 | 57,872 |
| 2022-01-07 | Lampert Mark N | Buy | 496,385 | 12.00 | 5,956,620 |
| 2022-01-06 | Lampert Mark N | Buy | 61,343 | 12.00 | 735,993 |
| 2021-10-12 | Edelman Joseph (10% Owner) | Sale | 7,306 | 13.40 | 97,900 |
| 2021-10-11 | Edelman Joseph (10% Owner) | Sale | 21,826 | 12.59 | 274,789 |
| 2021-10-08 | Edelman Joseph (10% Owner) | Sale | 7,500 | 13.28 | 99,600 |
| 2021-10-07 | Edelman Joseph (10% Owner) | Sale | 13,368 | 14.93 | 199,517 |
| 2021-09-21 | Berger Franklin M (Director) | Buy | 3,786 | 14.30 | 54,139 |
| 2021-09-21 | Lampert Mark N | Buy | 11,033 | 13.94 | 153,833 |
| 2021-09-13 | Lampert Mark N | Buy | 392,269 | 16.49 | 6,468,515 |
| 2021-07-06 | Lampert Mark N | Buy | 269,723 | 15.25 | 4,113,275 |
| 2021-07-01 | Lampert Mark N | Buy | 317,279 | 15.65 | 4,965,416 |
| 2021-05-24 | Lampert Mark N | Buy | 1,361 | 15.89 | 21,633 |
| 2021-05-21 | Lampert Mark N | Buy | 121,986 | 15.94 | 1,944,700 |
| 2021-05-19 | Lampert Mark N | Buy | 17,268 | 15.88 | 274,284 |
| 2021-05-18 | Lampert Mark N | Buy | 191,197 | 16.65 | 3,183,430 |
| 2021-05-13 | Lampert Mark N | Buy | 58,000 | 14.26 | 827,196 |
| 2021-04-27 | Cormorant Private Healthcare Fund Ii, Lp | Buy | 450,000 | 17.00 | 7,650,000 |
| 2021-04-27 | Edelman Joseph (10% Owner) | Buy | 550,000 | 17.00 | 9,350,000 |
| 2021-04-27 | Lewis Joseph (10% Owner) | Buy | 1,025,000 | 17.00 | 17,425,000 |
| 2021-04-23 | Berger Franklin M (Director) | Buy | 125,000 | 16.39 | 2,048,750 |
| 2021-04-23 | Lewis Joseph (10% Owner) | Buy | 150,000 | 15.93 | 2,388,750 |
Insider trading activities including stock purchases, stock sales, and option exercises of RAIN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Rain Oncology Inc. (symbol RAIN, CIK number 1724979) see the Securities and Exchange Commission (SEC) website.